Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 3284 entries
View as:

Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy

Phase: N/A Priority: Normal
NCT ID: NCT06948396 Org: User:
Start: 06/30/25 End: 05/30/27 Due: 05/30/28

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05775159 Org: User:
Start: 04/24/23 End: 12/14/26 Due: 12/14/27

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00039013 Org: User:
Start: 03/31/02 End: 06/30/03 Due: 06/30/04

Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin

Phase: N/A Priority: Normal
NCT ID: NCT00770302 Org: User:
Start: 10/31/08 End: 10/31/08 Due: 10/31/09

Study to Investigate Safety and Tolerability of a Single Dose of AZD6482

Phase: N/A Priority: Normal
NCT ID: NCT00688714 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06267729 Org: User:
Start: 03/12/24 End: 06/30/27 Due: 06/30/28

A Phase IV Study in Drug-Naive Patients With T2DM in China

Phase: N/A Priority: Normal
NCT ID: NCT03344341 Org: User:
Start: 12/15/17 End: 05/24/19 Due: 05/24/20

National Acalabrutinib Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05437250 Org: User:
Start: 09/13/22 End: 11/15/26 Due: 11/15/27

Nexium Dyspepsia/AST

Phase: N/A Priority: Normal
NCT ID: NCT00251992 Org: User:
Start: 12/31/02 End: 01/31/05 Due: 01/31/06

A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

Phase: N/A Priority: Normal
NCT ID: NCT04035486 Org: User:
Start: 07/02/19 End: 06/03/26 Due: 06/03/27

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Phase: N/A Priority: Normal
NCT ID: NCT06079671 Org: User:
Start: 09/22/23 End: 10/18/29 Due: 10/18/30

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06450197 Org: User:
Start: 08/28/24 End: 05/21/27 Due: 05/21/28

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Phase: N/A Priority: Normal
NCT ID: NCT06120491 Org: User:
Start: 11/21/23 End: 04/30/31 Due: 04/30/32

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Phase: N/A Priority: Normal
NCT ID: NCT05110261 Org: User:
Start: 11/24/21 End: 11/24/25 Due: 11/24/26

Evaluate the Safety of Linaclotide in IBS-C Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT04462900 Org: User:
Start: 09/18/20 End: 02/03/23 Due: 02/03/24

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Phase: N/A Priority: Normal
NCT ID: NCT02388295 Org: User:
Start: 04/27/15 End: 09/19/16 Due: 09/19/17

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT01265836 Org: User:
Start: 03/31/11 End: 03/31/13 Due: 03/31/14

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02063230 Org: User:
Start: 03/31/14 End: 11/30/14 Due: 11/30/15

German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00567021 Org: User:
Start: 09/30/05 End: 12/31/05 Due: 12/31/06

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Phase: N/A Priority: Normal
NCT ID: NCT05667064 Org: User:
Start: 05/10/23 End: 12/31/26 Due: 12/31/27

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Phase: N/A Priority: Normal
NCT ID: NCT01949870 Org: User:
Start: 10/31/13 End: 08/31/14 Due: 08/31/15

Bioequivalence of Bicalutamide New Formulation in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01416870 Org: User:
Start: 07/31/10 End: 11/30/10 Due: 11/30/11

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06563102 Org: User:
Start: 09/11/24 End: 11/10/25 Due: 11/10/26

Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00316082 Org: User:
Start: 06/30/06 End: 11/30/08 Due: 11/30/09

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)

Phase: N/A Priority: Normal
NCT ID: NCT04609878 Org: User:
Start: 12/15/20 End: 03/21/25 Due: 03/21/26